2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.

{"article_title":"2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines.","author":"Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ","journal_title":"Journal of the American College of Cardiology","issn":"1558-3597","isbn":"","publication_date":"2022-12-13","volume":"80","issue":"24","first_page":"e223","page_count":"","accession_number":"36334952","doi":"10.1016\/j.jacc.2022.08.004","publisher":"Elsevier Biomedical","doctype":"Practice Guideline","subjects":"United States; American Heart Association; Aortic Diseases diagnosis; Aortic Diseases therapy; United States; Humans; Universities","interest_area":["Cardiology"],"abstract":"Aim: The \"2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease\" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical presentation subsets (ie, asymptomatic, stable symptomatic, and acute aortic syndromes). Methods: A comprehensive literature search was conducted from January 2021 to April 2021, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through June 2022 during the guideline writing process, were also considered by the writing committee, where appropriate. Structure: Recommendations from previously published AHA\/ACC guidelines on thoracic aortic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with aortic disease have been developed. There is added emphasis on the role of shared decision making, especially in the management of patients with aortic disease both before and during pregnancy. The is also an increased emphasis on the importance of institutional interventional volume and multidisciplinary aortic team expertise in the care of patients with aortic disease. Copyright \u00a9 2022 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier Inc. All rights reserved.","url":"https:\/\/search.ebscohost.com\/login.aspx?direct=true&db=mdl&AN=36334952","isPdfLink":false,"isSAML":true,"an":"36334952","number_other":"","type_pub":"","issn_electronic":"1558-3597","languages":"English","language":"eng","date_entry":"Date Created: 20221105 Date Completed: 20221215 Latest Revision: 20231214","date_update":"20240105","titleSource":"Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Dec 13; Vol. 80 (24), pp. e223-e393. Date of Electronic Publication: 2022 Nov 02.","date_pub_cy":"","type_document":"","contract_publisher":"","authored_on":"2022-12-13","description":"Aim: The "2022 ACC\/AHA Guideline for the Diagnosis and Management of Aortic Disease" provides recommendations to guide clinicians in the diagnosis, genetic evaluation and family screening, medical therapy, endovascular and surgical treatment, and long-term surveillance of patients with aortic disease across its multiple clinical presentation subsets (ie, asymptomatic, stable symptomatic, and acute aortic syndromes).<br \/>Methods: A comprehensive literature search was conducted from January 2021 to April 2021, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through June 2022 during the guideline writing process, were also considered by the writing committee, where appropriate.<br \/>Structure: Recommendations from previously published AHA\/ACC guidelines on thoracic aortic disease, peripheral artery disease, and bicuspid aortic valve disease have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with aortic disease have been developed. There is added emphasis on the role of shared decision making, especially in the management of patients with aortic disease both before and during pregnancy. The is also an increased emphasis on the importance of institutional interventional volume and multidisciplinary aortic team expertise in the care of patients with aortic disease.<br \/> (Copyright © 2022 American College of Cardiology Foundation and the American Heart Association, Inc. Published by Elsevier Inc. All rights reserved.)","upload_link":"https:\/\/go.openathens.net\/redirector\/shalina.com?url=https:\/\/resolver.ebscohost.com\/openurl?sid=EBSCO:mdl&genre=article&issn=15583597&ISBN=&volume=80&issue=24&date=20221213&spage=e223&pages=e223-e393&title=Journal of the American College of Cardiology&atitle=2022%20ACC%2FAHA%20Guideline%20for%20the%20Diagnosis%20and%20Management%20of%20Aortic%C2%A0Disease%3A%20A%20Report%20of%20the%20American%20Heart%20Association%2FAmerican%20College%20of%20Cardiology%20Joint%20Committee%20on%20Clinical%20Practice%20Guidelines.&aulast=Isselbacher%20EM&id=DOI:10.1016\/j.jacc.2022.08.004&authtype=ip,shib&custid=ns346513&groupid=main&profile=eds","no_of_pages":"","authored_by":"Isselbacher EM, Preventza O, Hamilton Black Iii J, Augoustides JG, Beck AW, Bolen MA, Braverman AC, Bray BE, Brown-Zimmerman MM, Chen EP, Collins TJ, DeAnda A Jr, Fanola CL, Girardi LN, Hicks CW, Hui DS, Jones WS, Kalahasti V, Kim KM, Milewicz DM, Oderich GS, Ogbechie L, Promes SB, Ross EG, Schermerhorn ML, Times SS, Tseng EE, Wang GJ, Woo YJ"}